GSK still trying to put their house in order I think after the little "allegations of bribery" and "£300 million" problem (and I thought I had problems with UKOG!! lol). Mind you, BTG are expected to increase earnings by nearly 50% next year, so whoever wants them (if they do) will have to stump up big money. If not, then we'll just make a bit of money without them. Good-eeee!
<b>BTG says long – awaited varicose vein treatment has positive debut</b> 11 Nov 2014 - 09:19
(Adds CEO comments, shares)
Nov 11 (Reuters) – British drugs company BTG said it had started to roll out its varicose vein treatment to a positive response in the United States, as it said revenue for the year would be at the top end of forecasts.
Varithena, which has taken 18 years to reach the market after BTG acquired the technology, is an injectable foam that dissolves varicose veins rather than traditional techniques of stripping.
"The first commercial treatment was in August," Chief Executive Louise Makin said on Tuesday.
"The feedback from the physicians about the patients has been very good. We are very encouraged by that and everything is on track." She said the size of market for procedures reimbursed by insurers – for moderate to serious varicose veins – was about $250 million a year.
BTG was seeking approval to treat veins that were unsightly, but not yet painful, a market worth an additional $250 million, she said.
BTG, which also makes anti-venom drugs and products that deliver oncology drugs, posted a 25 percent rise in first-half revenue to 191.2 million pounds ($303 million), and a 15 percent rise in pretax profit to 37.6 million pounds.
The company said it expected its full-year revenue to be around the top end of its guidance of 330 million to 345 million pounds, despite adverse foreign exchange impacts.
Its shares were up 0.5 percent at 744 pence at 0851 GMT.
hope Finn Cap, Oriel and Singer keep these negative forecasts coming in as its helping the SP rise!!! Guess they must be looking at a different BTG than the rest of us or else they are just stupid. My best investment by a mile.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.